Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 130.00
Ask: 140.00
Change: -6.00 (-4.44%)
Spread: 10.00 (7.692%)
Open: 135.00
High: 136.00
Low: 129.00
Prev. Close: 135.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update - Significant Case Completion

15 Sep 2020 16:23

RNS Number : 0816Z
Manolete Partners PLC
15 September 2020
 

15 September 2020

Manolete Partners Plc

("Manolete" or the "Company")

Trading Update - Significant Case Completion

Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK, announces a trading update and the successful completion of one of the larger cases in its portfolio of UK insolvency claims (the "Claim").

During the current trading period since 31 March 2020, Manolete has completed 40 cases, including the Claim, which itself will generate a realised gain of approximately £4.1m and a net pre-tax profit contribution to the current accounting period of approximately £2.1m (net of the reversal of the previous unrealised gain of £2.0m that was previously allocated to the Claim). No material write offs were sustained in Manolete's portfolio of cases. New business has developed well in the five-month period to 31 August 2020, with 84 new cases being acquired/ funded, an increase of 65% over the same period last year.

Vintages Table

Financial

#

Number

%

Number

Open Cases

Closed Case

Total

Total

Total

IP Share

Manolete

Duration

ROI

MoM

Year

Investments

Completed

Completion

Outstanding

Investments

Investments

Invested

Recovered

Gain

Gain

completed cases

£000s

£000s

£000s

£000s

£000s

£000s

£000s

(months)

2010

3

3

100%

-

-

52

52

28

(24)

-

(24)

7

-46%

0.5

2011

-

-

100%

-

-

-

-

-

-

-

-

-

0%

0.0

2012

8

8

100%

-

-

763

763

2,524

1,761

580

1,181

18

155%

2.5

2013

10

10

100%

-

-

174

174

780

606

316

290

7

167%

2.7

2014

42

42

100%

-

-

594

594

3,884

3,290

2,427

863

10

145%

2.5

2015

39

39

100%

-

-

1,476

1,476

7,029

5,553

3,290

2,263

13

153%

2.5

2016

36

36

100%

-

-

1,907

1,907

9,009

7,102

4,123

2,979

15

156%

2.6

2017

31

30

97%

1

285

1,086

1,371

4,555

3,469

2,037

1,432

12

132%

2.3

2018

29

26

90%

3

1,090

1,625

2,715

19,564

17,939

12,783

5,156

13

317%

4.2

2019

59

41

69%

18

874

849

1,723

3,766

2,917

1,507

1,410

11

166%

2.7

2020

141

41

29%

100

2,182

932

3,114

6,551

5,619

3,016

2,603

7

279%

3.8

2021 YTD

89

4

4%

85

853

44

897

157

113

56

57

2

130%

2.3

487

280

57%

207

5,284

9,502

14,786

57,847

48,345

30,135

18,210

11

192%

2.9

As at 4 September 2020

Note: The Vintages table excludes 22 Cartel Cases and is net of deductions for bad debt provisions.

The Claim

The Company, alongside the other interested parties in the Claim, has entered into a settlement agreement (the "Settlement Agreement") with the former directors of an insolvent UK company (the "Defendants"). The Claim was consensually settled pursuant to the Settlement Agreement, with no admission of liability or any wrongdoing by any party to the Settlement Agreement.

The Claim was settled for a gross amount of £15.0m of which £4.7m is payable in cash to Manolete. This crystallises a realised gain for Manolete of £4.1m representing a 17.4x Money Multiple and a Return on Investment of 1,640%.

Manolete will first receive its total costs of approximately £250k as a first priority payment from the settlement proceeds. Of the remaining settlement proceeds of £14.75m, Manolete will receive 55% of the first £750k; 45% of the next £750k; 35% of the next £3.5m; and 25% of the remaining £9.75m.

To allow the Defendants time to liquidate and generate assets, the £15.0m settlement proceeds will be paid in instalments as follows: £160k within four months, a further £1.0m within 18 months, a further £1.2m 18 months later and then seven annual payments of approximately £1.8m per annum.

The Claim was purchased by Manolete during its financial year ended 31 March 2018. As at 31 March 2020, the end of the Company's last financial year, Manolete had estimated the fair value of the Claim based on assumed settlement proceeds of £5.5m and a resultant fair value unrealised gain of £2.0m (please refer to case number 1 on page 16 of Manolete's "Results for the Year Ended 31 March 2020": https://investors.manolete-partners.com/results-reports/results-centre dated 3 July 2020. That document provides an analysis of the fair values underlying 17 of the larger 35 cases within the Company's portfolio of 152 ongoing cases UK insolvency claims).

The largest creditor in the insolvent estate relating to the Claim is HMRC. Manolete understands that creditors are expected to receive a significant payment of approximately £10.0m.

Steven Cooklin, CEO of Manolete, commented: "We are very pleased with the latest period of current trading and the significant outcome on one of our larger claims. Not only for our shareholders but also for the large return it generates for the creditors, particularly HMRC, which is the largest creditor in that insolvent company estate by far. This case serves to highlight the excellent returns our business model generates for all stakeholders, as well as the strong Ethical, Social and Governance principles that guide the way we operate.

That case settled at £15m and so was materially higher than our conservative estimated fair value which was based on a settlement sum of £5.5m. As at the year ended 31 March 2020, our team was managing 35 larger UK insolvency claims with headline values in the range of £1m to £40m, reflecting the marked increase in the average size of cases we have invested in, particularly since our IPO in December 2018. While litigation outcomes and returns are never simple to estimate, this result again highlights our conservative and measured approach to valuing unrealised gains".

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (2014/596/EU).

For further information, please contact:

 

Manolete Partners Plc via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

 

Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900

James Britton

Rishi Shah

Duncan Littlejohns

 

Liberum (Joint Broker) +44 (0)20 3100 2000

Richard Crawley

James Greenwood

 

Instinctif Partners (Financial PR)

Tim Linacre +44 (0)7949 939237

Lewis Hill +44 (0)7837 674600

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVAVRRKUKAAR
Date   Source Headline
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
16th Nov 20237:00 amRNSHalf Year Results
9th Nov 20231:50 pmRNSNOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION
25th Oct 20239:32 amRNSPresenting at Proactive One2One Investor Forum
18th Oct 20237:00 amRNSTrading Update
19th Sep 20235:15 pmRNSResult of AGM
1st Aug 202311:33 amRNSUpdate regarding the PACCAR Matter
1st Aug 20237:00 amRNSGrant of Share Options
20th Jul 20237:00 amRNSGrant of Share Options
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20234:57 pmRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSThird Year: Band 1 Insolvency Litigation Funding
22nd Jun 20237:00 amRNSAudited results for the year ended 31 March 2023
13th Jun 202310:30 amRNSInvestor Presentation via Investor Meet Company
13th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSBlock Listing Six Monthly Return
22nd May 20237:00 amRNSRetail Investor Presentation at Mello2023
20th Apr 202312:30 pmRNSCORRECTION Further Trading Update
20th Apr 20237:00 amRNSFurther Trading Update
14th Mar 20231:49 pmRNSTrading Update
6th Feb 20237:00 amRNSHire of Former Government Counter-Fraud Expert
21st Dec 20229:11 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSBlock listing Six Monthly Return
10th Nov 20227:00 amRNSHalf Year Results
3rd Nov 20227:00 amRNSNotice of HY Results, Retail Investor Presentation
23rd Sep 20222:37 pmRNSUpdate on case
20th Sep 20222:00 pmRNSResult of AGM
9th Sep 20227:00 amRNSH1 Trading Update
1st Aug 202210:29 amRNSTotal Voting Rights
1st Aug 20227:00 amRNSGrant of Share Options and deferred bonus award
5th Jul 20225:04 pmRNSNotice of AGM
1st Jul 20227:00 amRNSBand 1 Ranking for Insolvency Litigation Funding
23rd Jun 20227:01 amRNSDirectorate Change
23rd Jun 20227:00 amRNSAudited results for the year ended 31 March 2022
16th Jun 20227:00 amRNSRetail Investor Presentation
15th Jun 20227:00 amRNSNotice of Results
1st Jun 20227:00 amRNSBlock Listing Six Monthly Return
3rd May 20227:00 amRNSTotal Voting Rights
26th Apr 20227:00 amRNSUpdate to recent Trading Statement & cash receipt
11th Apr 20227:00 amRNSTrading and business update
1st Mar 20227:00 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSAppointment of Independent Non-Executive Director
4th Jan 20223:34 pmRNSTotal Voting Rights
3rd Dec 20217:00 amRNSGrant of Share Options
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 202111:03 amRNSDirector/PDMR Dealings
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.